recommend prescribing medications for prophylaxis to prevent P jirovecii pneumonia. Prophylaxis to prevent P jirovecii pneumonia is discussed above in the GPA/MPA recommendations. The same considerations regarding prophylaxis to prevent this condition in patients with GPA/MPA apply to those with EGPA. DISCUSSION In this guideline, we present the first ACR/Vasculitis Foundation recommendations for the management of GPA, MPA, and EGPA. Although these recommendations provide a general guide for